StockData
Rigel Pharmaceuticals Inc logo

Rigel Pharmaceuticals Inc (RIGL) stock

RIGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/30
$42.92−0.81 (-1.85%)

Close on Nov 17, 2026Market cap $801.74MP/E 2.7Yield –

Rigel Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Rigel Pharmaceuticals's market cap was $875.21M on Nov 11, 2026, against $926.97M a year earlier. Over the last 5 years it ranged from $112.39M to $1.01B, with a median of $301.12M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$875.21M+11.3%
2025Dec 31, 2025$786.34M+166.6%
2024Dec 31, 2024$295.00M+18.5%
2023Dec 29, 2023$248.92M-0.8%
2022Dec 30, 2022$251.01M-44.8%
2021Dec 31, 2021$454.60M-23.0%
2020Dec 31, 2020$590.27M+64.8%
2019Dec 31, 2019$358.23M+23.3%
2018Dec 31, 2018$290.55M-20.7%
2017Dec 29, 2017$366.22M+74.0%
2016Dec 30, 2016$210.47M-20.8%
2015Dec 31, 2015$265.62M+34.1%
2014Dec 31, 2014$198.14M-7.3%
2013Dec 31, 2013$213.66M-54.2%
2012Dec 31, 2012$466.44M-17.0%
2011Dec 30, 2011$562.03M+82.6%
2010Dec 31, 2010$307.80M–

More Rigel Pharmaceuticals figures

See a number that looks wrong?